Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04711915
PHASE1
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Sponsor: Yale University
View on ClinicalTrials.gov
Summary
The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.
Key Details
Gender
All
Age Range
21 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2021-03-17
Completion Date
2026-12-01
Last Updated
2025-08-03
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
0.1 mg/kg Dimethyltryptamine (DMT)
0.1 mg/kg DMT
DRUG
0.3 mg/kg Dimethyltryptamine (DMT)
0.3 mg/kg DMT
Locations (1)
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine
West Haven, Connecticut, United States